
Clinical Trials - May 14, 2015
Ebola Vaccine Regimen Tested
Preliminary results from a Phase 1 first-in-human study of the Ebola prime-boost vaccine regimen of Bavarian Nordic’s MVA-BN® Filo vaccine and the AdVac® vaccine from the Janssen Pharmaceutical Companies of Johnson & Johnson were presented by Janssen at a meeting of the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee. […]